Flt1 Peptide - Hyaluronic Acid Conjugate Micelle-Like NanoparticlesEncapsulating Genistein for the Treatment of Occular Neovascularization

Category
Bioactive Materials: Nanomedicines
Year
2012
Authors
Hyemin Kim, Jun-Sub Choi, Ki Su Kim , Jeong-A Yang , Choun-Ki Joo, and Sei Kwang Hahn
Institutions
Department of Material Science and Engineering, Pohang University of Science and Technology (POSTECH), Korea; Department of Opthalmology and Visual Science, College of Medicine, The Catholic University of Korea, Korea
Summary

Flt1 peptide - hyaluronic acid (HA) conjugate micellelike nanoparticles encapsulating genistein, an inhibitor of tyrosine-specific protein kinase, were developed for a combination therapy to treat ocular neovascularization. In vitro biological activity of the micelles was verified by the anti-proliferation of human umbilical vein endothelial cells (HUVECs). The corneal neovascularization in silver nitrate cauterized corneas of SD rats was significantly suppressed by the treatment with genistein/Flt1 peptide - HA micelles. The retinal vascular hyperpermeability was also drastically reduced in diabetic retinopathy model rats after treatment with the micelles.